145 related articles for article (PubMed ID: 38093297)
1. Hyperglycemia with hypogonadism and growth hormone deficiency in a 17-year-old male with H syndrome: the first case report from Syria.
Hamsho S; Alaswad M; Sleiay M; Alhusseini A
BMC Endocr Disord; 2023 Dec; 23(1):274. PubMed ID: 38093297
[TBL] [Abstract][Full Text] [Related]
2. Cases with the H syndrome presenting with skin and bone findings.
Kose H; Baskaya MD; Kilic SS
Australas J Dermatol; 2024 Jun; 65(4):337-341. PubMed ID: 38421823
[TBL] [Abstract][Full Text] [Related]
3. The H syndrome is caused by mutations in the nucleoside transporter hENT3.
Molho-Pessach V; Lerer I; Abeliovich D; Agha Z; Abu Libdeh A; Broshtilova V; Elpeleg O; Zlotogorski A
Am J Hum Genet; 2008 Oct; 83(4):529-34. PubMed ID: 18940313
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Histochemical, and Molecular Study of Three Turkish Siblings Diagnosed with H Syndrome, and Literature Review.
Simsek E; Simsek T; Eren M; Yilmaz E; Arik D; Cilingir O; Ceylaner S; Harmancı K
Horm Res Paediatr; 2019; 91(5):346-355. PubMed ID: 30625464
[TBL] [Abstract][Full Text] [Related]
5. H syndrome treated with Tocilizumab: two case reports and literature review.
Jacquot R; Jouret M; Valentin MG; Richard M; Jamilloux Y; Rousset F; Emile JF; Haroche J; Steinmüller L; Zekre F; Phan A; Belot A; Seve P
Front Immunol; 2023; 14():1061182. PubMed ID: 37638031
[TBL] [Abstract][Full Text] [Related]
6. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
[TBL] [Abstract][Full Text] [Related]
7. H syndrome with a novel homozygous SLC29A3 mutation in two sisters.
Demir D; Aktaş Karabay E; Sözeri B; Gürsoy F; Akgün Doğan Ö; Topaktaş E; Zindancı İ
Pediatr Dermatol; 2020 Nov; 37(6):1135-1138. PubMed ID: 32776596
[TBL] [Abstract][Full Text] [Related]
8. Early-onset sensorineural hearing loss is a prominent feature of H syndrome.
Ramot Y; Sayama K; Sheffer R; Doviner V; Hiller N; Kaufmann-Yehezkely M; Zlotogorski A
Int J Pediatr Otorhinolaryngol; 2010 Jul; 74(7):825-7. PubMed ID: 20399510
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygous SLC29A3 mutation causes H syndrome in a Moroccan patient: A case report.
Bakhchane A; Kindil Z; Charoute H; Benchikhi K; Khadir K; Nadifi S; Baline K; Roky R; Barakat A
Curr Res Transl Med; 2016; 64(2):65-8. PubMed ID: 27316388
[TBL] [Abstract][Full Text] [Related]
10. 'H-syndrome': a multisystem genetic disorder with cutaneous clues.
Mori KS; Balachandran K; Asirvatham AR; Mahadevan S
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33947670
[TBL] [Abstract][Full Text] [Related]
11. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
[TBL] [Abstract][Full Text] [Related]
12. H syndrome: novel and recurrent mutations in SLC29A3.
Priya TP; Philip N; Molho-Pessach V; Busa T; Dalal A; Zlotogorski A
Br J Dermatol; 2010 May; 162(5):1132-4. PubMed ID: 20199539
[TBL] [Abstract][Full Text] [Related]
13. [H syndrome: First reported paediatric case in Latin America].
Abarca Barriga HH; Trubnykova M; Polar Córdoba V; Ramos Diaz KJ; Aviles Alfaro N
Rev Chil Pediatr; 2016; 87(6):494-499. PubMed ID: 27143505
[TBL] [Abstract][Full Text] [Related]
14. H syndrome: 5 new cases from the United States with novel features and responses to therapy.
Bloom JL; Lin C; Imundo L; Guthery S; Stepenaskie S; Galambos C; Lowichik A; Bohnsack JF
Pediatr Rheumatol Online J; 2017 Oct; 15(1):76. PubMed ID: 29041934
[TBL] [Abstract][Full Text] [Related]
15. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmologic Findings in H Syndrome: A Unique Diagnostic Clue.
Molho-Pessach V; Mechoulam H; Siam R; Babay S; Ramot Y; Zlotogorski A
Ophthalmic Genet; 2015; 36(4):365-8. PubMed ID: 24547910
[TBL] [Abstract][Full Text] [Related]
17. The H Syndrome: A Genodermatosis.
Bhatti S; Jamil A; Siddiqui SH; Yaqoob U; Virk LN; Bhatti A
Cureus; 2018 Jun; 10(6):e2763. PubMed ID: 30101042
[TBL] [Abstract][Full Text] [Related]
18. The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations.
Molho-Pessach V; Agha Z; Aamar S; Glaser B; Doviner V; Hiller N; Zangen DH; Raas-Rothschild A; Ben-Neriah Z; Shweiki S; Elpeleg O; Zlotogorski A
J Am Acad Dermatol; 2008 Jul; 59(1):79-85. PubMed ID: 18410979
[TBL] [Abstract][Full Text] [Related]
19. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
[TBL] [Abstract][Full Text] [Related]
20. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
